Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 27,570 | -8,185 | -6,333 | 57,353 | 57,233 |
| Depreciation Amortization | 48,664 | 29,786 | 10,442 | 34,026 | 24,551 |
| Income taxes - deferred | -8,833 | -9,464 | -668 | -11,810 | -8,741 |
| Accounts receivable | -25,180 | -37,638 | 21,637 | -33,497 | -39,294 |
| Other Working Capital | -35,356 | -84,897 | 7,683 | -68,267 | -41,684 |
| Other Operating Activity | 28,211 | 77,813 | -9,104 | 55,012 | 61,874 |
| Operating Cash Flow | $35,076 | $-32,585 | $23,657 | $32,817 | $53,939 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 200,064 | 200,064 | 200,064 | 26,312 | -12,921 |
| PPE Investments | -14,709 | -8,482 | -4,223 | -29,913 | -23,968 |
| Net Acquisitions | -691,348 | -697,183 | -697,183 | N/A | N/A |
| Purchase Sale Intangibles | 59,546 | N/A | 4,000 | -13,000 | -11,000 |
| Other Investing Activity | 53,996 | -1,550 | 4,000 | -13,000 | -11,000 |
| Investing Cash Flow | $-451,997 | $-507,151 | $-497,342 | $-16,601 | $-47,889 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,035,000 | 1,035,000 | 435,000 | N/A | N/A |
| Debt Repayment | -435,000 | -435,000 | N/A | N/A | N/A |
| Common Stock Issued | 99,248 | 93,703 | 3,065 | 11,097 | 8,961 |
| Other Financing Activity | -178,728 | -179,121 | -17,171 | 3,317 | 1,736 |
| Financing Cash Flow | $520,520 | $514,582 | $420,894 | $14,414 | $10,697 |
| Exchange Rate Effect | -70 | 572 | 1,011 | -369 | -889 |
| Beginning Cash Position | 214,873 | 214,873 | 214,873 | 184,612 | 184,612 |
| End Cash Position | 318,402 | 190,291 | 163,093 | 214,873 | 200,470 |
| Net Cash Flow | $103,529 | $-24,582 | $-51,780 | $30,261 | $15,858 |
| Free Cash Flow | |||||
| Operating Cash Flow | 35,076 | -32,585 | 23,657 | 32,817 | 53,939 |
| Capital Expenditure | -14,709 | -8,482 | -4,223 | -29,913 | -23,968 |
| Free Cash Flow | 20,367 | -41,067 | 19,434 | 2,904 | 29,971 |